Osmotic blood-brain barrier disruption: Computerized tomographic monitoring of chemotherapeutic agent delivery

The present study describes a canine model of transient reversible blood-brain barrier disruption with hyperosmolar mannitol infusion into the internal carotid artery. Studies in this model show that osmotic blood-brain barrier disruption before intracarotid infusion of methotrexate results in markedly elevated (therapeutic) levels of drug in the ipsilateral cerebral hemisphere. Levels in the cerebrospinal fluid correlate poorly and inconsistently with brain levels. Computerized tomograms in this canine model provide a noninvasive monitor of the degree, time-course, and localization of osmotic blood-brain barrier disruption.

[1]  Charles Tator.  Chemotherapy of brain tumors. Uptake of tritiated methotrexate by a transplantable intracerebral ependymoblastoma in mice. , 1972, Journal of neurosurgery.

[2]  W. Shapiro,et al.  Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections. , 1975, The New England journal of medicine.

[3]  Stanley I. Rapoport,et al.  Blood-Brain Barrier in Physiology and Medicine , 1976 .

[4]  R. Benjamin,et al.  Adriamycin chemotherapy—efficacy, safety, and pharmacologic basis of an intermittent single high‐dosage schedule , 1974, Cancer.

[5]  S. Rapoport.  Osmotic opening of the blood-brain barrier. , 1978, Ciba Foundation symposium.

[6]  H. Kimelberg,et al.  Direct administration of methotrexate into the central nervous system of primates. Part 1: Distribution and degradation of methotrexate in nervous and systemic tissue after intraventricular injection. , 1978, Journal of neurosurgery.

[7]  Y. Wang,et al.  Methotrexate in blood, urine, and cerebrospinal fluid of children receiving high doses by infusion. , 1976, Clinical chemistry.

[8]  S. Rosenberg,et al.  Use of plasma pharmacokinetics to predict and prevent methotrexate toxicity. , 1977, The New England journal of medicine.

[9]  D. Rall,et al.  Uptake and distribution of 3 H-methotrexate by the murine ependymoblastoma. , 1972, Journal of the National Cancer Institute.

[10]  S. Rapoport,et al.  Equi-Osmolal Opening of the Blood-Brain Barrier in the Rabbit by Different Contrast Media , 1974, Acta radiologica: diagnosis.

[11]  Posner Jb.  Management of central nervous system metastases. , 1977, Seminars in oncology.

[12]  D. Bigner,et al.  Chemotherapy of Brain Tumors: The Blood-Brain Barrier Is Not a Factor , 1977 .